NBD AI Bulletin - Hangzhou Tigermed Consulting Co Ltd (the Company, SZ 300347, close price: 161.26 yuan) announced on September 16 that shareholder Ms. Zhuan Yin's stock reduction plan has passed the halfway mark but she hasn't offloaded any share.
The 2020 annual report shows that the main business of Hangzhou Tigermed Consulting is the service industry, accounting for 99.5% of revenue.
Hangzhou Tigermed Consulting Co., Ltd. is chaired by Ye Xiaoping, male, 58, Chinese national, no permanent residence abroad, Ph.D. from University of Oxford, the UK. The Company's general manager is Cao Xiaochun, 52, Chinese national, no permanent residence abroad, bachelor's degree, practicing pharmacist, deputy senior engineer.
(By Lan Suying)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.